It is well appreciated that persons with multiple myeloma have an increased risk of venous thrombosis. More recently, this relative risk has been shown to be increased further in these patients while on therapy with thalidomide and its derivatives. The mechanism of this increased risk for thrombosis has traditionally been attributed to traditional neoplasia risks for thrombosis, such as decreased mobility, surgical procedures, use of chemotherapy, and/or indwelling catheters.

Internationally renowned cancer physician Stanislaw Burzynski will be the keynote speaker at the first ever Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM) at the Dubai World Trade Centre from November 7-9 2008.

Burzynski has been using biologically active peptides, which he calls 'antineoplastons' for the last 30 years, to treat thousands of cancer patients at his Burzynski Clinic in Houston, Texas.

ABSTRACT

Background Smoldering (asymptomatic) multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Prognostic factors for the progression and outcome of this disease are unclear.

Over the last few years new immunoassays have emerged that allow the measurement of free immunoglobulin light chains (FLCs) in serum to a level of 2-4 mg/l and provide a much greater sensitivity than older methods, such as immunofixation, which is able to detect FLCs at a minimum concentration of 100-150 mg/l. The new FLC assay has enabled the detection of monoclonal protein in some patients with non-secretory myeloma and amyloidosis that were previously undetectable.

Newswise — May is National Cancer Research Awareness Month, but for nurse researchers at the Johns Hopkins University School of Nursing (JHUSON), every month is cancer research month. Their innovative studies examine the integration of mind, body, and spirit to help improve the quality of life for individuals of all ages with all types of cancer. Their results not only reshape nursing practice and education but also create new nursing tools and skills that can help ease the physical and emotional effects of a cancer diagnosis for patients and those who love them.

The MMASupport website is an excellent source of information for the myeloma survivor and caregiver alike.

This particular page includes many links that are resources for myeloma survivors.

This is a website where you can search for clinical trials.

This website includes lots of basic information about different treatments and also has a tool for finding clinical trials.

Multiple myeloma patients vary widely in how they respond to treatment, but now researchers at the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences have identified a small subset of genes whose activity could predict high-risk cases and potentially guide therapy in the future.